SCOPUS 정보 검색 플랫폼

Statistics in Medicine

Volumn 23, Issue 10, 2004, Pages 1503-1505

Should statisticians reporting to data monitoring committees be independent of the trial sponsor and leadership?

(2) Ellenberg, Susan S a,c George, Stephen L b

a US Food Drug Administration (United States)

b DUKE UNIVERSITY MEDICAL CENTER (United States)

c NONE (United States)

Author keywords

Clinical trials; Conflict of interest; Data monitoring; Interim analysis

Indexed keywords

ACCURACY; ARTICLE; CLINICAL STUDY; CONFIDENTIALITY; CONFLICT; CONSENSUS DEVELOPMENT; FOOD AND DRUG ADMINISTRATION; HUMAN; INFORMATION PROCESSING; LEADERSHIP; MEDICAL INFORMATION; MEDICAL SPECIALIST; ORGANIZATION AND MANAGEMENT; PROFESSIONAL STANDARD; RESPONSIBILITY; STATISTICAL ANALYSIS;

BIOMEDICAL AND BEHAVIORAL RESEARCH;

CLINICAL TRIALS DATA MONITORING COMMITTEES; CONFLICT OF INTEREST; DATA INTERPRETATION, STATISTICAL; ETHICS, PROFESSIONAL; GUIDELINES; HUMANS; LONGITUDINAL STUDIES; RANDOMIZED CONTROLLED TRIALS; RESEARCH PERSONNEL; STATISTICS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 2442686637 PISSN: 02776715 EISSN: None Source Type: Journal
DOI: 10.1002/sim.1784 Document Type: Article

Times cited : (21)

References (10)

1
- 0027286665
- Monitoring of clinical trials: Issues and recommendations
- Fleming TR, DeMets DL. Monitoring of clinical trials: issues and recommendations. Controlled Clinical Trials 1993; 14:183-197.
- (1993) Controlled Clinical Trials , vol.14 , pp. 183-197
- Fleming, T.R.¹ DeMets, D.L.²

2
- 0023413293
- Policies for study monitoring and interim reporting of results
- Green SJ, Fleming TR, O'Fallon JR. Policies for study monitoring and interim reporting of results. Journal of Clinical Oncology 1987; 5:1477-1484.
- (1987) Journal of Clinical Oncology , vol.5 , pp. 1477-1484
- Green, S.J.¹ Fleming, T.R.² O'Fallon, J.R.³

3
- 0028136211
- Some practical aspects of the interim monitoring of clinical trials
- Simon R. Some practical aspects of the interim monitoring of clinical trials. Statistics in Medicine 1994; 13:1401-1409.
- (1994) Statistics in Medicine , vol.13 , pp. 1401-1409
- Simon, R.¹

4
- 0027529215
- Some FDA perspectives on data monitoring in clinical trials in drug development
- O'Neill RT. Some FDA perspectives on data monitoring in clinical trials in drug development. Statistics in Medicine 1993; 12:601-608.
- (1993) Statistics in Medicine , vol.12 , pp. 601-608
- O'Neill, R.T.¹

5
- 0035147112
- Procedures of data and safety monitoring committees
- Pocock S, Furberg CD. Procedures of data and safety monitoring committees. American Heart Journal 2001; 141:289-294.
- (2001) American Heart Journal , vol.141 , pp. 289-294
- Pocock, S.¹ Furberg, C.D.²

6
- 0035094581
- Terms of reference for data and safety monitoring committees
- Packer M, Wittes J, Stump D. Terms of reference for data and safety monitoring committees. American Heart Journal 2001; 141:542-547.
- (2001) American Heart Journal , vol.141 , pp. 542-547
- Packer, M.¹ Wittes, J.² Stump, D.³

7
- 0037108141
- Monitoring clinical trials: Issues and controversies regarding confidentiality
- Fleming TR, Ellenberg SS, DeMets DL. Monitoring clinical trials: issues and controversies regarding confidentiality. Statistics in Medicine 2002; 21:2843-2851.
- (2002) Statistics in Medicine , vol.21 , pp. 2843-2851
- Fleming, T.R.¹ Ellenberg, S.S.² DeMets, D.L.³

8
- 0012792209
- Wiley: Chichester, UK
- Ellenberg SS, Fleming TR, DeMets DL. Data Monitoring Committees in Clinical Trials: A Practical Perspective. Wiley: Chichester, UK, 2002.
- (2002) Data Monitoring Committees in Clinical Trials: A Practical Perspective
- Ellenberg, S.S.¹ Fleming, T.R.² DeMets, D.L.³

9
- 0032430615
- Clinical trials and treatment effects monitoring
- Meinert CL. Clinical trials and treatment effects monitoring. Controlled Clinical Trials 1998; 19:515-522.
- (1998) Controlled Clinical Trials , vol.19 , pp. 515-522
- Meinert, C.L.¹

10
- 85069095020
- www.fda.gov/cber/gdlns/clindatmon.htm
- www.fda.gov/cber/gdlns/clindatmon.htm.

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.